Skip to content
Back to Guavy Wire
Stocks

Concurrent Investment Advisors Boosts Stake in Amgen Amid Q2 Earnings Beat

Instruments
AMGN
Share

Concurrent Investment Advisors LLC increased its Amgen Inc. (NASDAQ:AMGN) stake by 19.9% in Q2, according to its latest 13F filing with the SEC.

The firm purchased an additional 8,590 shares during the period, bringing its total holdings to 51,650 shares valued at $18,703,000 as of its most recent filing.

Amgen reported $6.29 earnings per share (EPS) for Q2, surpassing the consensus estimate of $5.62 by $0.67.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc